These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 35229733)

  • 1. Concerns over functional experiments, interpretation, and required controls. Reply.
    Hsieh WC; Chen SY
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229733
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns over functional experiments, interpretation, and required controls.
    Wang EC; Fielding CA; Stanton RJ
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229732
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19: Immunology, Immunopathogenesis and Potential Therapies.
    Bhardwaj A; Sapra L; Saini C; Azam Z; Mishra PK; Verma B; Mishra GC; Srivastava RK
    Int Rev Immunol; 2022; 41(2):171-206. PubMed ID: 33641587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of epitranscriptomics in trained innate immunity and COVID-19.
    Arumugam P; Jayaseelan VP
    Epigenomics; 2021 Jul; 13(14):1077-1080. PubMed ID: 34225477
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 pandemic and "survival of the fittest".
    Mukhra R; Krishan K; Kanchan T
    J Infect Dev Ctries; 2021 Oct; 15(10):1384-1387. PubMed ID: 34780359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunopathobiology of SARS-CoV-2 Infection.
    Patel M; Shahjin F; Cohen JD; Hasan M; Machhi J; Chugh H; Singh S; Das S; Kulkarni TA; Herskovitz J; Meigs DD; Chandra R; Hettie KS; Mosley RL; Kevadiya BD; Gendelman HE
    FEMS Microbiol Rev; 2021 Nov; 45(6):. PubMed ID: 34160586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
    Gupta R; Gant VA; Williams B; Enver T
    Int J Infect Dis; 2020 Oct; 99():381-385. PubMed ID: 32771640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trained Innate Immunity, Epigenetics, and Covid-19.
    Mantovani A; Netea MG
    N Engl J Med; 2020 Sep; 383(11):1078-1080. PubMed ID: 32905684
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 and immunity: quo vadis?
    Miyasaka M
    Int Immunol; 2021 Sep; 33(10):507-513. PubMed ID: 33569606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection in conjunctival tissue - Authors' reply.
    Hui KP; Peiris M; Nicholls JM; Chan MC
    Lancet Respir Med; 2020 Jul; 8(7):e58. PubMed ID: 32649922
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving Non-specific Immunity to Coronavirus Disease (COVID-19) by the Novelty, Diversity, and Quantity of Antigen.
    Boucher P; Boucher R
    Front Public Health; 2020; 8():393. PubMed ID: 32850603
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.
    Chumakov K; Avidan MS; Benn CS; Bertozzi SM; Blatt L; Chang AY; Jamison DT; Khader SA; Kottilil S; Netea MG; Sparrow A; Gallo RC
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection.
    Fiorcari S; Atene CG; Maffei R; Debbia G; Potenza L; Luppi M; Marasca R
    Haematologica; 2021 Aug; 106(8):2265-2268. PubMed ID: 33691383
    [No Abstract]   [Full Text] [Related]  

  • 16. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
    J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked changes in innate immunity associated with a mild course of COVID-19 in identical twins with athymia and absent circulating T cells.
    Colmenero-Velázquez A; Esteso G; Del Rosal T; Calvo Apalategui A; Reyburn H; López-Granados E
    J Allergy Clin Immunol; 2021 Feb; 147(2):567-568. PubMed ID: 33309039
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics.
    Chakrabarti S; Chakrabarti SS; Kaur U; Agrawal BK; Ganguly U; Jin K
    J Med Virol; 2021 Jul; 93(7):4094-4096. PubMed ID: 33755226
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 Pandemic and Its Effects on the Development of Immunity in Infancy.
    Rupp J; Härtel C
    Neonatology; 2021; 118(6):734-735. PubMed ID: 34515184
    [No Abstract]   [Full Text] [Related]  

  • 20. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.
    Lamadrid P; Alonso-Peña M; San Segundo D; Arias-Loste M; Crespo J; Lopez-Hoyos M
    Front Immunol; 2021; 12():651728. PubMed ID: 33859644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.